6-Mercaptopurine Inhibits Atherosclerosis in Apolipoprotein E*3-Leiden Transgenic Mice Through Atheroprotective Actions on Monocytes and Macrophages

Objective—6-Mercaptopurine (6-MP), the active metabolite of the immunosuppressive prodrug azathioprine, is commonly used in autoimmune diseases and transplant recipients, who are at high risk for cardiovascular disease. Here, we aimed to gain knowledge on the action of 6-MP in atherosclerosis, with a focus on monocytes and macrophages. Methods and Results—We demonstrate that 6-MP induces apoptosis of THP-1 monocytes, involving decreased expression of the intrinsic antiapoptotic factors B-cell CLL/Lymphoma-2 (Bcl-2) and Bcl2-like 1 (Bcl-xL). In addition, we show that 6-MP decreases expression of the monocyte adhesion molecules platelet endothelial adhesion molecule-1 (PECAM-1) and very late antigen-4 (VLA-4) and inhibits monocyte adhesion. Screening of a panel of cytokines relevant to atherosclerosis revealed that 6-MP robustly inhibits monocyte chemoattractant chemokine-1 (MCP-1) expression in macrophages stimulated with lipopolysaccharide (LPS). Finally, local delivery of 6-MP to the vessel wall, using a drug-eluting cuff, attenuates atherosclerosis in hypercholesterolemic apolipoprotein E*3-Leiden transgenic mice (P<0.05). In line with our in vitro data, this inhibition of atherosclerosis by 6-MP was accompanied with decreased lesion monocyte chemoattractant chemokine-1 levels, enhanced vascular apoptosis, and reduced macrophage content. Conclusion—We report novel, previously unrecognized atheroprotective actions of 6-MP in cultured monocytes/macrophages and in a mouse model of atherosclerosis, providing further insight into the effect of the immunosuppressive drug azathioprine in atherosclerosis.

[1]  E. Seidman,et al.  Use of Pharmacogenetics, Enzymatic Phenotyping, and Metabolite Monitoring to Guide Treatment with Azathioprine in Patients with Systemic Lupus Erythematosus , 2008, The Journal of Rheumatology.

[2]  M. Benedetti,et al.  Azathioprine in multiple sclerosis. , 2008, Mini reviews in medicinal chemistry.

[3]  G. Filippini,et al.  Azathioprine for multiple sclerosis. , 2007, The Cochrane database of systematic reviews.

[4]  P. Bonta,et al.  NR4A nuclear orphan receptors: protective in vascular disease? , 2007, Current opinion in lipidology.

[5]  Suzanne Cory,et al.  Bcl-2-regulated apoptosis: mechanism and therapeutic potential. , 2007, Current opinion in immunology.

[6]  A. Martini,et al.  Review: Macrophage activation syndrome in juvenile systemic lupus erythematosus: an under-recognized complication? , 2007, Lupus.

[7]  G. Kong,et al.  6-Mercaptopurine, an activator of Nur77, enhances transcriptional activity of HIF-1α resulting in new vessel formation , 2007, Oncogene.

[8]  P. Quax,et al.  Activation of Nuclear Receptor Nur77 by 6-Mercaptopurine Protects Against Neointima Formation , 2007, Circulation.

[9]  T. van der Poll,et al.  Nuclear Receptors Nur77, Nurr1, and NOR-1 Expressed in Atherosclerotic Lesion Macrophages Reduce Lipid Loading and Inflammatory Responses , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[10]  P. Quax,et al.  TR3 nuclear orphan receptor prevents cyclic stretch-induced proliferation of venous smooth muscle cells. , 2006, The American journal of pathology.

[11]  M. Barnett,et al.  The macrophage in MS: just a scavenger after all? Pathology and pathogenesis of the acute MS lesion , 2006, Multiple sclerosis.

[12]  A. Verhoeven,et al.  Characterization of human phagocyte-derived chitotriosidase, a component of innate immunity. , 2005, International immunology.

[13]  M. Sans,et al.  Reviewing the mechanism of action of thiopurine drugs: towards a new paradigm in clinical practice. , 2004, Medical science monitor : international medical journal of experimental and clinical research.

[14]  M. Dubinsky.  Azathioprine, 6-mercaptopurine in inflammatory bowel disease: pharmacology, efficacy, and safety. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[15]  S. Akira,et al.  Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[16]  P. Ordentlich,et al.  Identification of the Antineoplastic Agent 6-Mercaptopurine as an Activator of the Orphan Nuclear Hormone Receptor Nurr1* , 2003, Journal of Biological Chemistry.

[17]  K. S. A. Wansa,et al.  The AF-1 Domain of the Orphan Nuclear Receptor NOR-1 Mediates Trans-activation, Coactivator Recruitment, and Activation by the Purine Anti-metabolite 6-Mercaptopurine* , 2003, Journal of Biological Chemistry.

[18]  M. Neurath,et al.  CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes. , 2003, The Journal of clinical investigation.

[19]  C. Hellerbrand,et al.  Polymorphism of monocyte chemoattractant protein 1 in Crohn's disease , 2003, International Journal of Colorectal Disease.

[20]  L. Miller.  Cardiovascular Toxicities of Immunosuppressive Agents , 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[21]  Akira Takeshita,et al.  Anti-Monocyte Chemoattractant Protein-1 Gene Therapy Limits Progression and Destabilization of Established Atherosclerosis in Apolipoprotein E–Knockout Mice , 2002, Circulation.

[22]  P. Quax,et al.  Accelerated atherosclerosis by placement of a perivascular cuff and a cholesterol-rich diet in ApoE*3Leiden transgenic mice. , 2000, Circulation research.

[23]  Aldons J. Lusis,et al.  Atherosclerosis : Vascular biology , 2000 .

[24]  A. Griesmacher,et al.  Azathioprine and 6-mercaptopurine alter the nucleotide balance in endothelial cells. , 1999, Thrombosis Research.

[25]  A. Lusis,et al.  Blocking very late antigen-4 integrin decreases leukocyte entry and fatty streak formation in mice fed an atherogenic diet. , 1999, Circulation research.

[26]  M. Elices,et al.  Adhesion to vascular cell adhesion molecule 1 and fibronectin. Comparison of alpha 4 beta 1 (VLA-4) and alpha 4 beta 7 on the human B cell line JY. , 1992, The Journal of biological chemistry.